NEW YORK (GenomeWeb News) – The European Commission has awarded €540,000 ($728,438) to UK-based Forsite Diagnostics to help develop a rapid molecular diagnostic test for malaria, the company said on Monday.

The test is being developed as part of a three-year project called Diagmal to develop a test using fresh blood samples to confirm the presence of Plasmodium parasites, which causes malaria. Currently no molecular tests exist on the market exist for Plasmodium, Forsite, one of the collaborators on Diagmal, said.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: swapping yeast genes with human orthologs to study conservation of function, and more.

Hong Kong is using DNA phenotyping to shame litterers.

A study appearing in Cell suggests some metastatic castration-resistant prostate cancer patients could benefit from PARP inhibitor therapy.

NIH's Francis Collins writes that scientific advances are poised to help populations all over the world, but more scientists are needed to keep the momentum.